Andrew leads the Innovative Medicine Communication and Public Affairs team (C&PA) across Asia Pacific to deliver powerful strategies that support patients, enhance access and accelerate the business. The team is also charged with building and protecting the long-term reputation of J&J Innovative Medicine with both internal and external stakeholders.
Most recently, Andrew served as the senior C&PA counsellor to the Johnson & Johnson Japan President’s Council, and Chair of the Japan Community Impact Organization. In this role he was responsible for building, strengthening and shaping Johnson & Johnson’s reputation and communication efforts in Japan across the company’s entire MedTech, Consumer and Pharmaceuticals portfolio.
During his 14+ years at Johnson & Johnson, Andrew has worked in commercial, communications and government affairs functions. Before his time in Japan, he completed five years in the USA, initially in the global pharmaceuticals team where he directly supported the Worldwide Chairman, including staffing him as Chairman of PhRMA. He also held leadership roles for critical milestones such as the acquisition of Actelion (J&J’s largest ever acquisition), the development and launch of the business’ new global strategy and key reviews with the investment community. Subsequently he led communications teams in three of the company’s North American pharmaceutical business units. During this time, he developed a new approach to U.S. pharmaceutical TV advertising and helped pioneer new communications approaches for major issues.
Prior to his US assignment, Andrew led the transition and change management of the Janssen ANZ business to a more customer-focused model, creating and leading a team responsible for customer insights, customer experience design and multichannel marketing. He also founded the Janssen Health and Technology Challenge (HaTCH) which sought to inspire start-ups to solve healthcare challenges facing Australia.
Andrew holds Bachelor of Media and Bachelor of Laws degrees, Honours 1st Class, from Macquarie University; and graduated at the top of his MBA class from Macquarie Graduate School of Management.